Search the Newsroom
Filter By
News Type
Showing 1 - 10 of 49 results
A First Look at the Clinical Outcomes Data Archive
Our innovative fetal patient registry and data management system has made remarkable strides impacting both clinical care and research.
First-of-its-Kind Open-Analysis Platform for Pediatric Brain Tumors Provides Robust Data Resource for Childhood Cancer Research
Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor Network paves the way for new collaborative models to accelerate discoveries.
The Runway Fashion & Trunk Show Raises More Than $845,000 for CHOP’s Neuroscience Center
Children’s Hospital of Philadelphia hosted The Runway, presented by the Jacovini Family, a contemporary lunchtime fashion show at the Mann Center curated by top Philadelphia-area boutiques and designers with proceeds benefitting CHOP’s Neuroscience Center. This year, more than $845,000 was raised!
Harnessing Data to Accelerate Discovery and Treatment of Brain Tumors
Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.
Two CHOP Researchers Named 2022 STAT Wunderkinds
Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.
New Study Shows AML Ages Immune Cells, Leading to Poor Treatment Response
A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.
Study Finds Newly Formed “Immature” Neurons Appear in Brain Throughout Lifespan
CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.
First Approved CAR T-Cell Therapy Shows Continued Benefits Five Years Later
New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.
CHOP Researchers Develop Allogeneic CART for Relapsed or Refractory T-ALL Using Base Editing
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.
CHOP Brings Together Experts to Discuss Precision Medicine in Pediatric Cancer Care
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.